7 Results for "

ccr7 antagonist

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "ccr7 antagonist" in MCE Product Catalog:

  • Targets Recommended:
3
3 Cited Publications
Cat. No.: HY-133073
CAS No.: 681514-83-0
Purity:  99.19%
Synonyms: ccr7-Cmp2105
Research Areas:  

Cancer

CCR7 Ligand 1 (CCR7-Cmp2105) is an allosteric Ligand and antagonist for human CC chemokine receptor 7 (CCR7) with a Kd of 3 nM. CCR7 Ligand 1, thiadiazole-dioxide ligan, suppresses arrestin binding in response to activation by CCL19 with an IC50 of 7.3 μM .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-19974
CAS No.: 333994-00-6
Target:  

CCR HIV

Research Areas:  

Infection Endocrinology

TAK-220 is a selective and orally bioavailable CCR5 antagonist, with IC50s of 3.5 nM and 1.4 nM for inhibition on the binding of RANTES and MIP-1α to CCR5, respectively, but shows no effect on the binding to CCR1, CCR2b, CCR3, CCR4, or CCR7; TAK-220 also selectively inhibits HIV-1, with EC50s of 1.2 nM (HIV-1 KK), 0.72 nM (HIV-1 CTV), 1.7 nM (HIV-1 HKW), 1.7 nM (HIV-1 HNK), 0.93 nM (HIV-1 HTN), and 0.55 nM (HIV-1 HHA), and EC90s of 12 nM (HIV-1 KK), 5 nM (HIV-1 CTV), 12 nM (HIV-1 HKW), 28 nM (HIV-1 HNK), 15 nM (HIV-1 HTN), and 4 nM (HIV-1 HHA) in PBMCs.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-120427
CAS No.: 154212-56-3
Purity:  98.82%
Synonyms: NSC 658586
Target:  

CCR CXCR HIV HSV

Research Areas:  

Infection Inflammation/Immunology

Cosalane (NSC 658586) is a CCR7 (IC50 = 2.43 μM) and CXCR2 antagonist (IC50 = 0.66 μM). Cosalane is an inhibitor of HIV replication with a wide range of activity against HIV-1 isolates, HIV-2, Rauscher murine leukemia virus, HSV-1, HSV-2 and human cytomegalovirus. Cosalane inhibits both attachment of gp120 to CD4. Cosalane inhibits human and murine CCR7 in response to both CCL19 and CCL21 agonists. Cosalane can be studied in research for HIV or attenuating acute graft-versus-host disease (aGVHD) in allogeneic hematopoietic stem cell transplantation (HSCT) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-173052
CAS No.: 681511-84-2
Target:  

CXCR CCR Arrestin

Research Areas:  

Inflammation/Immunology

SLW131 is a CCR7 antagonist with a Ki value of 9.85 nM. SLW131 inhibits CCL19-induced Go protein activation with an IC50 of 29.4 μM, and suppresses β-arrestin2 recruitment with an IC50 of 6.0 μM. SLW131 serves as a probe for investigating the biological functions of CCR7 in cells. SLW131 is applicable to research related to rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-149096
CAS No.: 3048330-48-6
Purity:  99.55%
Target:  

CXCR

Research Areas:  

Others

CCR7 antagonist 1 (30c) is a dual CXCR2 (IC50 of 11.02 μM) and CCR7 (IC50 of 0.43 μM) antagonist .
loading...
    loading...
Cat. No.: HY-173491
CAS No.: 473728-04-0
Target:  

CXCR CCR

Research Areas:  

Inflammation/Immunology Cancer

CXCR2/CCR7 antagonist-1 (compound 6) is a potent CXCR2 and CCR7 dual antagonist with IC50s of 0.0046 and 0.0014 μM, respectively. CXCR2/CCR7 antagonist-1 can be used in the study of cancer metastasis and autoimmune diseases .
loading...
    loading...
Cat. No.: HY-181681
Target:  

CCR CXCR

Research Areas:  

Cancer

CXCR2 antagonist 10 (Compound 10b) is a CCR2 antagonist with an IC50 of 0.48 μM. CXCR2 antagonist 10 also exhibits antagonistic activity against CXCR2/CCR7, with IC50 values of 4.18 μM and 2.07 μM, respectively. CXCR2 antagonist 10 is applicable for cancer research .
loading...
    loading...